# Unexpected Malignancy in Women Undergoing Surgery for Uterine Fibroids

**Authors:** Bandana Bharali, Deepti Goswami, Nita Khurana

PMC · DOI: 10.7759/cureus.104342 · Cureus · 2026-02-26

## TL;DR

This study found that a small percentage of women undergoing surgery for uterine fibroids may have unexpected uterine malignancies, highlighting the need for preoperative counseling.

## Contribution

The study provides a prevalence estimate of unexpected uterine malignancy in women with fibroids and identifies clinical characteristics.

## Key findings

- Three cases of unexpected malignancy were found among 436 women undergoing surgery for fibroids.
- The prevalence of unexpected uterine malignancy was 0.68%.
- Two cases of smooth muscle tumours of uncertain malignant potential were also identified.

## Abstract

Background: Fibroids are the most common tumors of the uterus and female genital tract. There are several treatment modalities for fibroids, spanning from watchful waiting, medical management, and surgical management, of which surgery continues to be the mainstay of treatment. It has been observed that in a few rare cases, what are presumed to be fibroids preoperatively can reveal malignancy in histopathology, the consequences of which can be grave.

Objective: The primary objective of this study was to estimate the prevalence of unexpected uterine malignancy in women undergoing surgery for uterine fibroids. The secondary objective was to study the clinical characteristics of patients with such unexpected uterine malignancy detected on histopathology.

Methods: We conducted an observational study including all patients who underwent myomectomy or hysterectomy, by any route, for uterine fibroid at the Department of Obstetrics and Gynecology, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi. Any case with preoperative diagnosis of endometrial hyperplasia with atypia or any suspected malignancy was excluded. Data were collected over a period of three years from gynecologic operation theatre records, histopathology reports, and patient files. The prevalence of unexpected uterine malignancy was estimated overall.

Results: A total of 436 women underwent surgery for uterine fibroids in our study; among them, three cases of unexpected malignancy and two cases of smooth muscle tumours of uncertain malignant potential (STUMP) were identified, thus making the prevalence of 0.68% for unexpected uterine malignancy in fibroids.

Conclusion: The absolute risk of unexpected malignancy in women with fibroids is low, but the difficulty in preoperative diagnosis remains a challenge. Hence, patients should be counselled preoperatively about the likelihood of such a finding in the final histopathology.

## Full-text entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** Sarcomas (MESH:D012509), smooth muscle tumour of uncertain (MESH:D018235), pelvic mass (MESH:C536030), endometrial stroma sarcoma (MESH:D018203), endometrial hyperplasia (MESH:D004714), bleeding (MESH:D006470), endometrial polyp (MESH:D014591), Fibroids (MESH:D007889), postoperative pain (MESH:D010149), Malignancy (MESH:D009369), tumours of the uterus (MESH:D014594), gynecologic malignancies (MESH:D005833), epithelial endometrial malignancies (MESH:D002277), abdominal pain (MESH:D015746), leiomyosarcoma (MESH:D007890), STUMP (MESH:D019042), pelvic pain (MESH:D017699)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946682/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12946682/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946682/full.md

---
Source: https://tomesphere.com/paper/PMC12946682